{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:11:00Z","timestamp":1791857460774,"version":"4.3.4"},"reference-count":61,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007560","name":"Chiesi Farmaceutici","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.chest.2021.07.008","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T01:30:27Z","timestamp":1626139827000},"page":"2019-2029","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Workup of Severe Asthma"],"prefix":"10.1016","volume":"160","author":[{"given":"Simon","family":"Couillard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Wechsler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian D.","family":"Pavord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.chest.2021.07.008_bib1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.chest.2021.07.008_bib2","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jaci.2014.08.042","article-title":"The prevalence of severe refractory asthma","volume":"135","author":"Hekking","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.chest.2021.07.008_bib3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaci.2011.11.006","article-title":"Severe asthma: advances in current management and future therapy","volume":"129","author":"Barnes","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.chest.2021.07.008_bib4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1001\/jama.2016.19627","article-title":"Reevaluation of diagnosis in adults with physician-diagnosed asthma","volume":"317","author":"Aaron","year":"2017","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.chest.2021.07.008_bib5","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.chest.2020.03.052","article-title":"Performance characteristics of spirometry with negative bronchodilator response and methacholine challenge testing and implications for asthma diagnosis","volume":"158","author":"Selvanathan","year":"2020","journal-title":"Chest"},{"issue":"2 Suppl","key":"10.1016\/j.chest.2021.07.008_bib6","doi-asserted-by":"crossref","first-page":"18S","DOI":"10.1378\/chest.10-0088","article-title":"Direct challenge tests: airway hyperresponsiveness in asthma: its measurement and clinical significance","volume":"138","author":"Cockcroft","year":"2010","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.chest.2021.07.008_bib7","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1164\/rccm.201808-1516OC","article-title":"Exacerbation patterns in adults with asthma in England: a population-based study","volume":"199","author":"Bloom","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.chest.2021.07.008_bib8","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.rmed.2004.10.008","article-title":"Measurement properties and interpretation of three shortened versions of the asthma control questionnaire","volume":"99","author":"Juniper","year":"2005","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.chest.2021.07.008_bib9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaci.2003.09.008","article-title":"Development of the asthma control test: a survey for assessing asthma control","volume":"113","author":"Nathan","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.chest.2021.07.008_bib10","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jaci.2009.06.053","article-title":"The minimally important difference of the Asthma Control Test","volume":"124","author":"Schatz","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.chest.2021.07.008_bib11","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1183\/20734735.0362-2018","article-title":"Over-and under-diagnosis in asthma","volume":"15","author":"Kavanagh","year":"2019","journal-title":"Breathe"},{"issue":"6","key":"10.1016\/j.chest.2021.07.008_bib12","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/MCP.0000000000000526","article-title":"Sleep and asthma","volume":"24","author":"Kavanagh","year":"2018","journal-title":"Curr Opin Pulm Med"},{"issue":"2","key":"10.1016\/j.chest.2021.07.008_bib13","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1183\/13993003.01359-2015","article-title":"Treatable traits: toward precision medicine of chronic airway diseases","volume":"47","author":"Agusti","year":"2016","journal-title":"Eur Respir J"},{"issue":"10118","key":"10.1016\/j.chest.2021.07.008_bib14","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(17)30879-6","article-title":"After asthma: redefining airways diseases","volume":"391","author":"Pavord","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.chest.2021.07.008_bib15","article-title":"Asthma in pregnancy: an update","author":"Couillard","year":"2020","journal-title":"Obstet Med"},{"issue":"9795","key":"10.1016\/j.chest.2021.07.008_bib16","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(11)60971-9","article-title":"Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial","volume":"378","author":"Powell","year":"2011","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.chest.2021.07.008_bib17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1164\/rccm.200510-1589OC","article-title":"Effects of smoking cessation on lung function and airway inflammation in smokers with asthma","volume":"174","author":"Chaudhuri","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2021.07.008_bib18","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jaip.2016.01.016","article-title":"Individualized household allergen intervention lowers allergen level but not asthma medication use: a randomized controlled trial","volume":"4","author":"DiMango","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.chest.2021.07.008_bib19","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJM200002103420607","article-title":"Occupational respiratory diseases","volume":"342","author":"Beckett","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.chest.2021.07.008_bib20","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1016\/j.jaip.2020.06.031","article-title":"Assessment and management of occupational asthma","volume":"8","author":"Cullinan","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.chest.2021.07.008_bib21","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/thoraxjnl-2011-200257","article-title":"Non-adherence in difficult asthma: time to take it seriously","volume":"67","author":"Heaney","year":"2012","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.chest.2021.07.008_bib22","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1164\/rccm.202104-1040LE","article-title":"Feno non-suppression identifies corticosteroid-resistant type-2 signaling in severe asthma","volume":"204","author":"Couillard","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2021.07.008_bib23","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1164\/ajrccm.153.1.8542158","article-title":"Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients","volume":"153","author":"Kharitonov","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2021.07.008_bib24","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1164\/rccm.201806-1182OC","article-title":"Remotely monitored therapy and nitric oxide suppression identifies nonadherence in severe asthma","volume":"199","author":"Heaney","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2021.07.008_bib25","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.jaip.2020.10.059","article-title":"Clinical outcomes in people with difficult-to-control asthma using electronic monitoring to support medication adherence","volume":"9","author":"Boddy","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.chest.2021.07.008_bib26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S2213-2600(13)70012-2","article-title":"Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial","volume":"1","author":"Papi","year":"2013","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.chest.2021.07.008_bib27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S2213-2600(13)70007-9","article-title":"Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial","volume":"1","author":"Patel","year":"2013","journal-title":"Lancet Respir Med"},{"issue":"4","key":"10.1016\/j.chest.2021.07.008_bib29","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1378\/chest.14-3056","article-title":"Dedicated severe asthma services improve health-care use and quality of life","volume":"148","author":"Gibeon","year":"2015","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.chest.2021.07.008_bib30","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1164\/rccm.200711-1754OC","article-title":"Cluster analysis and clinical asthma phenotypes","volume":"178","author":"Haldar","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.chest.2021.07.008_bib31","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200903-0392OC","article-title":"T-helper type 2-driven inflammation defines major subphenotypes of asthma","volume":"180","author":"Woodruff","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2021.07.008_bib32","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/resp.13494","article-title":"Time to FOCUS on oral corticosteroid stewardship in asthma management","volume":"24","author":"McBrien","year":"2019","journal-title":"Respirology"},{"issue":"1","key":"10.1016\/j.chest.2021.07.008_bib33","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jaci.2017.03.044","article-title":"Inflammatory phenotypes in patients with severe asthma are associated with distinct airway microbiology","volume":"141","author":"Taylor","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.chest.2021.07.008_bib34","doi-asserted-by":"crossref","first-page":"2000194","DOI":"10.1183\/13993003.00194-2020","article-title":"Airway abundance of Haemophilus influenzae predicts response to azithromycin in adults with persistent uncontrolled asthma","volume":"56","author":"Taylor","year":"2020","journal-title":"Eur Respir J"},{"issue":"9171","key":"10.1016\/j.chest.2021.07.008_bib35","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/S0140-6736(99)01813-9","article-title":"Non-eosinophilic corticosteroid unresponsive asthma","volume":"353","author":"Pavord","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.chest.2021.07.008_bib36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S2213-2600(20)30397-0","article-title":"Composite type-2 biomarker strategy versus a symptom\u2013risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial","volume":"9","author":"Heaney","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"9","key":"10.1016\/j.chest.2021.07.008_bib37","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1164\/rccm.202003-0729LE","article-title":"Blood eosinophil depletion with mepolizumab, benralizumab, and prednisolone in eosinophilic asthma","volume":"202","author":"Moran","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2021.07.008_bib38","article-title":"P13 Exhaled nitric oxide and blood eosinophil count in predicting sputum inflammatory type in a heterogeneous airways disease population. In: Thorax","author":"Lehtim\u00e4ki","year":"2019","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.chest.2021.07.008_bib39","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1183\/09031936.93.06091368","article-title":"Increased amount of nitric oxide in exhaled air of asthmatics","volume":"6","author":"Alving","year":"1993","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.chest.2021.07.008_bib40","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1365-2222.2008.02969.x","article-title":"IL-13 induced increases in nitrite levels are primarily driven by increases in inducible nitric oxide synthase as compared with effects on arginases in human primary bronchial epithelial cells","volume":"38","author":"Chibana","year":"2008","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.chest.2021.07.008_bib41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1165\/rcmb.2006-0419OC","article-title":"Measurement of IL-13-induced iNOS-derived gas phase nitric oxide in human bronchial epithelial cells","volume":"37","author":"Suresh","year":"2007","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.chest.2021.07.008_bib42","doi-asserted-by":"crossref","first-page":"1901633","DOI":"10.1183\/13993003.01633-2019","article-title":"Clinical utility of fractional exhaled nitric oxide (Feno) in severe asthma management","author":"Menzies-Gow","year":"2020","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.chest.2021.07.008_bib43","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (Feno) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.chest.2021.07.008_bib44","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1164\/rccm.202001-0133OC","article-title":"A\u00a0phase 2a, double-blind, placebo-controlled randomized trial of inhaled TLR9 agonist AZD1419 in asthma","volume":"203","author":"Psallidas","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2021.07.008_bib45","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00413-2021","article-title":"Patient characteristics, biomarkers, and exacerbation risk in severe, uncontrolled asthma [Published online ahead of print June 10, 2021]","author":"Kraft","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.chest.2021.07.008_bib46","author":"Busse","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"10","key":"10.1016\/j.chest.2021.07.008_bib47","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1164\/rccm.201903-0599LE","article-title":"Prognostic and predictive value of blood eosinophil count, fractional exhaled nitric oxide, and their combination in severe asthma: a post hoc analysis","volume":"200","author":"Shrimanker","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2021.07.008_bib48","article-title":"Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide","author":"Couillard","year":"2021","journal-title":"Thorax"},{"issue":"19","key":"10.1016\/j.chest.2021.07.008_bib49","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMoa2034975","article-title":"Tezepelumab in adults and adolescents with severe, uncontrolled asthma","volume":"384","author":"Menzies-Gow","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.chest.2021.07.008_bib50","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/thoraxjnl-2019-213929","article-title":"British Thoracic Society guideline for the use of long-term macrolides in adults with respiratory disease","volume":"75","author":"Smith","year":"2020","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.chest.2021.07.008_bib51","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1172\/JCI95693","article-title":"Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction","volume":"128","author":"Dunican","year":"2018","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.chest.2021.07.008_bib52","first-page":"A4531","article-title":"CT Mucus Score Predicts Benralizumab Response in Severe Asthma","volume":"203","author":"Kooner","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2021.07.008_bib54","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.anai.2014.07.025","article-title":"Diagnosis and management of rhinosinusitis: a practice parameter update","volume":"113","author":"Peters","year":"2014","journal-title":"Ann Allergy, Asthma Immunol"},{"issue":"15","key":"10.1016\/j.chest.2021.07.008_bib55","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJMoa0806290","article-title":"Efficacy of esomeprazole for treatment of poorly controlled asthma","volume":"360","author":"Mastronarde","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.chest.2021.07.008_bib56","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1182\/blood-2014-11-551614","article-title":"How I treat hypereosinophilic syndromes","volume":"126","author":"Klion","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.chest.2021.07.008_bib57","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jaut.2014.01.018","article-title":"Diagnosis and classification of eosinophilic granulomatosis with polyangiitis (formerly named Churg-Strauss syndrome)","volume":"48-49","author":"Mouthon","year":"2014","journal-title":"J\u00a0Autoimmun"},{"issue":"1","key":"10.1016\/j.chest.2021.07.008_bib58","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2017.04.009","article-title":"Oral corticosteroid exposure and adverse effects in asthmatic patients","volume":"141","author":"Sullivan","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"155","key":"10.1016\/j.chest.2021.07.008_bib59","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0151-2019","article-title":"Short-course systemic corticosteroids in asthma: Striking the balance between efficacy and safety","volume":"29","author":"Price","year":"2020","journal-title":"Eur Respir Rev"},{"issue":"3","key":"10.1016\/j.chest.2021.07.008_bib60","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1164\/rccm.201904-0903SO","article-title":"Systematic literature review of systemic corticosteroid use for asthma management","volume":"201","author":"Bleecker","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.chest.2021.07.008_bib61","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.4049\/jimmunol.1800709","article-title":"Bronchial allergen challenge of\u00a0patients\u00a0with atopic asthma triggers an alarmin (IL-33,\u00a0TSLP,\u00a0and\u00a0IL-25) response in the airways epithelium\u00a0and\u00a0submucosa","volume":"201","author":"Wang","year":"2018","journal-title":"J\u00a0Immunol"},{"issue":"3","key":"10.1016\/j.chest.2021.07.008_bib62","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jaci.2020.03.037","article-title":"Human TH1\u00a0and\u00a0TH2 cells targeting rhinovirus and allergen coordinately\u00a0promote allergic asthma","volume":"146","author":"Muehling","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.chest.2021.07.008_bib63","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.chest.2021.05.021","article-title":"Managing corticosteroid-related comorbidities in severe asthma","volume":"160","author":"Sood","year":"2021","journal-title":"Chest"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369221013258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369221013258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T23:01:29Z","timestamp":1762124489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369221013258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0012369221013258"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2021.07.008","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Workup of Severe Asthma","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2021.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc under license from the American College of Chest Physicians.","name":"copyright","label":"Copyright"}]}}